Sulindac sulfide inhibits the proliferation of colon cancer cells: Diminished expression of the proliferation markers PCNA and Ki-67

被引:53
|
作者
Qiao, L
Shiff, SJ
Rigas, B
机构
[1] CORNELL UNIV,COLL MED,DEPT MED,NEW YORK,NY 10021
[2] ROCKEFELLER UNIV,NEW YORK,NY 10021
关键词
NSAIDs; colon cancer; sulindac; apoptosis; proliferation; cyclooxygenase;
D O I
10.1016/S0304-3835(97)04740-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We evaluated the effect of sulindac sulfide (SS), which reduces cell number and induces apoptosis in cultured colon cancer cells (CCCs), on expression of the proliferation markers PCNA and Ki-67 in HT-29 and HCT-15 CCCs; only the former express cyclooxygenases. DNA content and PCNA/Ki-67 expression were analyzed by bivariate flow cytometry. SS inhibited cell proliferation, determined by the reduced expression of PCNA and Ki-67, roughly by half at 72 h, and induced apoptosis (accounting for about two-thirds and one-third of the reduction in cell number, respectively). A similar effect of SS occurred in HT-29 and HCT-15 CCCs, and also in non-colonic cells, indicating that this rather general effect of SS on cultured cells is not dependent on inhibition of prostaglandin synthesis. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 50 条
  • [21] Positivity of the proliferation marker Ki-67 in noncycling cells
    van Oijen, MGCT
    Medema, RH
    Slootweg, PJ
    Rijksen, G
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (01) : 24 - 31
  • [22] Proliferation marker Ki-67 in early breast cancer
    Urruticoechea, A
    Smith, IE
    Dowsett, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7212 - 7220
  • [23] Thymidylate synthase expression in rectal cancer and proliferation, assessed by cyclin A and Ki-67 expression
    Edler, D
    Hallström, M
    Ragnhammar, P
    Blomgren, H
    ANTICANCER RESEARCH, 2002, 22 (05) : 3113 - 3116
  • [24] Quantitative analysis of the proliferation of epidermal cells using a human skin organ culture system and the effect of DbcAMP using markers of proliferation (BrdU, Ki-67, PCNA)
    Onuma, H
    Mastui, C
    Morohashi, M
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2001, 293 (03) : 133 - 138
  • [25] Quantitative analysis of the proliferation of epidermal cells using a human skin organ culture system and the effect of DbcAMP using markers of proliferation (BrdU, Ki-67, PCNA)
    H. Onuma
    Chihiro Mastui
    Masaaki Morohashi
    Archives of Dermatological Research, 2001, 293 : 133 - 138
  • [26] EXPRESSION OF KI-67 - A PROLIFERATION-ASSOCIATED ANTIGEN - IN PROSTATIC-CANCER
    NILSSON, S
    NORDGREN, H
    EKLOV, S
    LOGDAHL, M
    ACTA ONCOLOGICA, 1991, 30 (02) : 177 - 179
  • [27] Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers
    Lopes, JM
    Hannisdal, E
    Bjerkehagen, B
    Bruland, OS
    Danielsen, HE
    Pettersen, EO
    Sobrinho-Simces, M
    Nesland, JM
    ANALYTICAL CELLULAR PATHOLOGY, 1998, 16 (01): : 45 - 62
  • [28] Correlation between Proliferation Markers: PCNA, Ki-67, MCM-2 and Antiapoptotic Protein Bcl-2 in Colorectal Cancer
    Guzinska-Ustymowicz, Katarzyna
    Pryczynicz, Anna
    Kemona, Andrzej
    Czyzewska, Jolanta
    ANTICANCER RESEARCH, 2009, 29 (08) : 3049 - 3052
  • [29] COMPARATIVE FLOW CYTOMETRIC ASSESSMENT OF KI-67 AND PCNA PROLIFERATION ANTIGENS IN SOLID NEOPLASMS
    ELNAGGAR, AK
    TEAGUE, K
    LABORATORY INVESTIGATION, 1994, 70 (01) : A141 - A141
  • [30] Determination of proliferation in breast cancer by immunohistochemical detection of Ki-67
    Christgen, M.
    Winkens, W.
    Kreipe, H. H.
    PATHOLOGE, 2014, 35 (01): : 54 - 60